These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 7950376)

  • 1. Separation of active and inactive forms of recombinant human plasminogen activator inhibitor type 1 (PAI-1) expressed in Chinese hamster ovary cells: comparison with native human PAI-1.
    Strömqvist M; Andersson JO; Boström S; Deinum J; Ehnebom J; Enquist K; Johansson T; Hansson L
    Protein Expr Purif; 1994 Aug; 5(4):309-16. PubMed ID: 7950376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and characterization of recombinant porcine plasminogen activator inhibitor-1.
    Bijnens AP; Knockaert I; Cousin E; Kruithof EK; Declerck PJ
    Thromb Haemost; 1997 Feb; 77(2):350-6. PubMed ID: 9157595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VLHL plasminogen activator inhibitor spontaneously reactivates from the latent to active form.
    Jankun J; Aleem AM; Selman SH; Basrur V; Skrzypczak-Jankun E
    Int J Mol Med; 2009 Jan; 23(1):57-63. PubMed ID: 19082507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis.
    Björquist P; Ehnebom J; Inghardt T; Hansson L; Lindberg M; Linschoten M; Strömqvist M; Deinum J
    Biochemistry; 1998 Feb; 37(5):1227-34. PubMed ID: 9477948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different structural requirements for plasminogen activator inhibitor 1 (PAI-1) during latency transition and proteinase inhibition as evidenced by phage-displayed hypermutated PAI-1 libraries.
    Stoop AA; Eldering E; Dafforn TR; Read RJ; Pannekoek H
    J Mol Biol; 2001 Jan; 305(4):773-83. PubMed ID: 11162091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of human tissue prokallikrein and kallikrein isoforms expressed in Chinese hamster ovary cells.
    Lu HS; Hsu YR; Narhi LO; Karkare S; Lin FK
    Protein Expr Purif; 1996 Sep; 8(2):227-37. PubMed ID: 8812867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant plasminogen activator inhibitor type 1: a review of structural, functional, and biological aspects.
    Reilly TM; Mousa SA; Seetharam R; Racanelli AL
    Blood Coagul Fibrinolysis; 1994 Feb; 5(1):73-81. PubMed ID: 8180342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of recombinant plasminogen activator inhibitor-1 in the active conformation by refolding from inclusion bodies.
    Lee HJ; Im H
    Protein Expr Purif; 2003 Sep; 31(1):99-107. PubMed ID: 12963346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of recombinant human antithrombin containing the prelatent form in Chinese hamster ovary cells.
    Mochizuki S; Miyano K; Kondo M; Hirose M; Masaki A; Ohi H
    Protein Expr Purif; 2005 Jun; 41(2):323-31. PubMed ID: 15866718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
    Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
    Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
    Jankun J; Aleem AM; Selman SH; Skrzypczak-Jankun E; Lysiak-Szydlowska W; Grafos N; Fryer HJ; Greenfield RS
    Int J Mol Med; 2007 Nov; 20(5):683-7. PubMed ID: 17912461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasminogen activator-inhibitor 1: biochemical, structural and functional studies].
    Declerck P
    Verh K Acad Geneeskd Belg; 1993; 55(5):457-73. PubMed ID: 8128782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.
    Lawrence D; Strandberg L; Grundström T; Ny T
    Eur J Biochem; 1989 Dec; 186(3):523-33. PubMed ID: 2514093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetically controlled folding of the serpin plasminogen activator inhibitor 1.
    Wang Z; Mottonen J; Goldsmith EJ
    Biochemistry; 1996 Dec; 35(51):16443-8. PubMed ID: 8987976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of recombinant rat plasminogen activator inhibitor-1 and development of immunological tools for its quantitation.
    Ngo TH; Verheyen S; Knockaert I; Declerck PJ
    J Pharm Belg; 1997; 52(4):165-6. PubMed ID: 9316343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.
    Chen YQ; Sloan-Lancaster J; Berg DT; Richardson MA; Grinnell B; Tseng-Crank J
    Thromb Haemost; 2001 Dec; 86(6):1563-72. PubMed ID: 11776328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
    Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD
    Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distal hinge of plasminogen activator inhibitor-1 involves its latency transition and specificities toward serine proteases.
    Wang Q; Shaltiel S
    BMC Biochem; 2003 Jul; 4():5. PubMed ID: 12848892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation.
    Kjøller L; Kanse SM; Kirkegaard T; Rodenburg KW; Rønne E; Goodman SL; Preissner KT; Ossowski L; Andreasen PA
    Exp Cell Res; 1997 May; 232(2):420-9. PubMed ID: 9168821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 19F NMR studies of plasminogen activator inhibitor-1.
    Abbott GL; Blouse GE; Perron MJ; Shore JD; Luck LA; Szabo AG
    Biochemistry; 2004 Feb; 43(6):1507-19. PubMed ID: 14769027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.